Notice2021-19444
Request for Nominations for Voting Members on a Public Advisory Committee; the Tobacco Products Scientific Advisory Committee
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 8, 2021
Issuing agencies
Health and Human Services DepartmentFood and Drug Administration
Abstract
The Food and Drug Administration (FDA) is requesting nominations for members to serve on the Tobacco Products Scientific Advisory Committee, in the Center for Tobacco Products. FDA seeks to include the views of women and men, members of all racial and ethnic groups, and individuals with and without disabilities on its advisory committees and, therefore encourages nominations of appropriately qualified candidates from these groups.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 171 (Wednesday, September 8, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 171 (Wednesday, September 8, 2021)]
[Notices]
[Pages 50362-50363]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-19444]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2018-N-3263]
Request for Nominations for Voting Members on a Public Advisory
Committee; the Tobacco Products Scientific Advisory Committee
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is requesting
nominations for members to serve on the Tobacco Products Scientific
Advisory Committee, in the Center for Tobacco Products. FDA seeks to
include the views of women and men, members of all racial and ethnic
groups, and individuals with and without disabilities on its advisory
committees and, therefore encourages nominations of appropriately
qualified candidates from these groups.
DATES: Nominations received on or before November 8, 2021 will be given
first consideration for membership on the Tobacco Products Scientific
Advisory Committee. Nominations received after November 8, 2021 will be
considered for nomination to the committee as later vacancies occur.
ADDRESSES: All nominations for membership should be sent electronically
by logging into the FDA Advisory Nomination Portal: <a href="https://www.accessdata.fda.gov/scripts/FACTRSPortal/FACTRS/index.cfm">https://www.accessdata.fda.gov/scripts/FACTRSPortal/FACTRS/index.cfm</a>.
Information about becoming a member on an FDA advisory committee can
also be obtained by visiting FDA's website by using the following link:
<a href="https://www.fda.gov/AdvisoryCommittees/default.htm">https://www.fda.gov/AdvisoryCommittees/default.htm</a>.
FOR FURTHER INFORMATION CONTACT: Regarding all nomination questions for
membership, the primary contact is: Serina Hunter-Thomas, Office of
Science, Center for Tobacco Products, Food and Drug Administration,
Center for Tobacco Products, Document Control Center, Bldg. 71, Rm.
G335, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, 1-877-
287-1373 (choose Option 5), email: <a href="/cdn-cgi/l/email-protection#7f2b2f2c3e3c3f191b1e5117170c51181009"><span class="__cf_email__" data-cfemail="df8b8f8c9e9c9fb9bbbef1b7b7acf1b8b0a9">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: FDA is requesting nomination for voting
members on the Tobacco Products Scientific Advisory Committee.
[[Page 50363]]
I. General Description of the Committee Duties
The Tobacco Products Scientific Advisory Committee (the Committee)
advises the Commissioner of FDA (the Commissioner) or designee in
discharging responsibilities related to the regulation of tobacco
products. The Committee reviews and evaluates behavior, dependence, and
health issues, among others, relating to tobacco products and provides
appropriate advice, information, and recommendations to the
Commissioner.
II. Criteria for Voting Members
The Committee shall consist of 12 members, including the Chair.
Members and the Chair are selected by the Commissioner or designee from
among individuals knowledgeable in the fields of science, medicine,
medical ethics, or technology involving the manufacture, evaluation, or
use of tobacco products. Almost all non-Federal members of this
committee serve as Special Government Employees. The Committee shall
include nine technically qualified voting members, selected by the
Commissioner or designee. The nine voting members shall be scientists,
physicians, dentists, or healthcare professionals practicing in the
areas of oncology, pulmonology, cardiology, toxicology, pharmacology,
addiction, epidemiology, behavioral health, or any other relevant
specialty. One member shall be an officer or employee of a state or
local government or of the Federal Government. The final voting member
shall be a representative of the general public. Members will be
invited to serve for terms of up to 4 years.
III. Nomination Procedures
Any interested person may nominate one or more qualified
individuals for membership on the advisory committee. Self-nominations
are also accepted. Nominations must include a current, complete
r[eacute]sum[eacute] or curriculum vitae for each nominee, including
current business address and/or home address, telephone number, and
email address if available and a signed copy of the Acknowledgement and
Consent form available at the FDA Advisory Nomination Portal (see
ADDRESSES). Nominations must also specify the advisory committee for
which the nominee is recommended. Nominations must also acknowledge
that the nominee is aware of the nomination unless self-nominated. FDA
will ask potential candidates to provide detailed information
concerning such matters related to financial holdings, employment, and
research grants and/or contracts to permit evaluation of possible
sources of conflicts of interest.
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.
Dated: September 2, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2021-19444 Filed 9-7-21; 8:45 am]
BILLING CODE 4164-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 8, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.